Skip to main content

Advertisement

Log in

Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP)

  • Review Article
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Metamorphosis, the transformation of one normal tissue or organ system into another, is a biological process rarely studied in higher vertebrates or mammals, but exemplified pathologically by the extremely disabling autosomal dominant disorder fibrodysplasia ossificans progressiva (FOP). The recurrent single nucleotide missense mutation in the gene encoding activin receptor IA/activin-like kinase-2 (ACVR1/ALK2), a bone morphogenetic protein type I receptor that causes skeletal metamorphosis in all classically affected individuals worldwide, is the first identified human metamorphogene. Physiological studies of this metamorphogene are beginning to provide deep insight into a highly conserved signaling pathway that regulates tissue stability following morphogenesis, and that when damaged at a highly specific locus (c.617G > A; R206H), and triggered by an inflammatory stimulus permits the renegade metamorphosis of normal functioning connective tissue into a highly ramified skeleton of heterotopic bone. A comprehensive understanding of the process of skeletal metamorphosis, as revealed by the rare condition FOP, will lead to the development of more effective treatments for FOP and, possibly, for more common disorders of skeletal metamorphosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kaplan FS, Glaser DL, Pignolo RJ, Shore EM (2005) Introduction. Clin Rev Bone Miner Metab 3(3–4):175–177

    Article  Google Scholar 

  2. Kaplan FS, Glaser DL, Shore EM, Deirmengian GK, Gupta R, Delai P, Morhart R, Smith R, Le Merrer M, Rogers JG, Connor JM, Kitterman JA (2005) The phenotype of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 3:183–188

    Article  Google Scholar 

  3. Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho T-J, Choi IH, Connor JM, Delai P, Glaser DL, Le Merrer M, Morhart R, Rogers JG, Smith R, Triffitt JT, Urtizberea JA, Zasloff M, Brown MA, Kaplan FS (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossi-ficans progressiva. Nat Genet 38:525–527

    Article  PubMed  CAS  Google Scholar 

  4. Cohen RB, Hahn GV, Tabas J, Peeper J, Levitz CL, Sando A, Sando N, Zasloff M, Kaplan FS (1993) The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. J Bone Joint Surg Am 75:215–219

    PubMed  CAS  Google Scholar 

  5. Rocke DM, Zasloff M, Peeper J, Cohen RB, Kaplan FS (1994) Age and joint-specific risk of initial heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Relat Res 301:243–248

    PubMed  Google Scholar 

  6. Kaplan FS, Tabas J, Gannon FH, Finkel G, Hahn GV, Zasloff MA (1993) The histopathology of fibrodysplasia ossificans progressiva: an endochondral process. J Bone Joint Surg Am 75:220–230

    PubMed  CAS  Google Scholar 

  7. Gannon FH, Valentine BA, Shore EM, Zasloff MA, Kaplan FS (1998) Acute lymphocytic infiltration in an extremely early lesion of fibrodysplasia ossificans progressiva. Clin Orthop Relat Res 346:19–25

    Article  PubMed  Google Scholar 

  8. Glaser DL, Economides AN, Wang L, Liu X, Kimble RD, Fandl JP, Wilson JM, Stahl N, Kaplan FS, Shore EM (2003) In vivo somatic cell gene transfer of an engineered noggin mutein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg Am 85:2332–2342

    PubMed  Google Scholar 

  9. Pignolo RJ, Suda RK, Kaplan FS (2005) The fibrodysplasia ossificans progressiva lesion. Clin Rev Bone Miner Metab 3:195–200

    Article  Google Scholar 

  10. Lanchoney TF, Cohen RB, Rocke DM, Zasloff MA, Kaplan FS (1995) Permanent heterotopic ossification at the injection site after diphtheria-tetanus-pertussis immunizations in children who have fibrodysplasia ossificans progressiva. J Pediatr 126:762–764

    Article  PubMed  CAS  Google Scholar 

  11. Janoff HB, Zasloff MA, Kaplan FS (1996) Submandibular swelling in patients with fibrodysplasia ossificans progressiva. Otolaryngol Head Neck Surg 114:599–604

    Article  PubMed  CAS  Google Scholar 

  12. Luchetti W, Cohen RB, Hahn GV, Rocke DM, Helpin M, Zasloff M, Kaplan FS (1996) Severe restriction in jaw movement after routine injection of local anesthetic in patients who have fibrodysplasia ossificans progressiva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81:21–25

    Article  PubMed  CAS  Google Scholar 

  13. Glaser DL, Rocke DM, Kaplan FS (1998) Catastrophic falls in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Relat Res 346:110–116

    Article  PubMed  Google Scholar 

  14. Scarlett RF, Rocke DM, Kantanie S, Patel JB, Shore EM, Kaplan FS (2004) Influenza-like viral illnesses and flare-ups of fibrodysplasia ossificans progressiva. Clin Orthop Relat Res 423:275–279

    Article  PubMed  Google Scholar 

  15. Connor JM, Evans DA (1982) Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg Br 64:76–83

    PubMed  CAS  Google Scholar 

  16. Smith R (1988) Fibrodysplasia (myositis) ossificans progressiva: clinical lessons from a rare disease. Clin Orthop Relat Res 346:7–14

    Google Scholar 

  17. Kaplan FS, Shore EM, Connor JM (2002) Fibrodysplasia ossificans progressiva (FOP). In: Royce PM, Steinmann B (eds) Connective Tissue and Its Heritable Disorders: Molecular, Genetic, and Medical Aspects, 2nd edn. Wiley-Liss, New York, pp 827–840

    Google Scholar 

  18. Kaplan FS, Glaser DL, Hebela N, Shore EM (2004) Heterotopic ossification. J Am Acad Orthop Surg 12:116–125

    PubMed  Google Scholar 

  19. Kaplan FS, Glaser DL, Shore EM (2006) Fibrodysplasia (myositis) ossificans progressiva. In: Favus MJ (ed). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 6th edn. The American Society for Bone and Mineral Research, Washington, DC, pp 450–453

    Google Scholar 

  20. Moriatis JM, Gannon FH, Shore EM, Bilker W, Zasloff MA, Kaplan FS (1997) Limb swelling in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Relat Res 336:247–253

    Article  PubMed  Google Scholar 

  21. Kaplan FS, Glaser DL (2005) Thoracic insufficiency syndrome in patients with fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 3:213–216

    Article  Google Scholar 

  22. Shore EM, Feldman GJ, Xu M, Kaplan FS (2005) The genetics of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 3:201–204

    Article  CAS  Google Scholar 

  23. Kitterman JA, Kantanie S, Rocke DM, Kaplan FS (2005) Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Pediatrics 116:654–661

    Article  Google Scholar 

  24. Kaplan FS, Xu M, Glaser DL, Collins F, Connor M, Kitterman J, Sillence D, Zackai E, Ravitsky V, Zasloff M, Ganguly A, Shore E (2008) Early diagnosis of fibrodysplasia ossificans progressiva (FOP). Pediatrics 121:e1295–1300

    Article  PubMed  Google Scholar 

  25. Schaffer AA, Kaplan FS, Tracy MR, O’Brien ML, Dormans JP, Shore EM, Harland RM, Kusumi K (2005) Developmental anomalies of the cervical spine in patients with fibrodysplasia ossificans progressiva are distinctly different from those in patients with Klippel-Feil syndrome. Spine 30:1379–1385

    Article  PubMed  Google Scholar 

  26. Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides A, Kwaitowski W, Affolter M, Vale WW, Izpisua-Belmonte JC, Choe S (2002) Structural basis of BMP signalling inhibition by Noggin, a novel cystine knot protein. Nature (Lond) 420:636–642

    Article  CAS  Google Scholar 

  27. Lucotte G, Semonin O, Lutz P (1999) A de novo heterozygous deletion of 42 base-pairs in the noggin gene of a fibrodysplasia ossificans progressiva. Clin Genet 56:469–470

    Article  PubMed  CAS  Google Scholar 

  28. Semonin O, Fontaine K, Daviaud C, Ayuso C, Lucotte G (2001) Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva. Am J Med Genet 102:314–317

    Article  PubMed  CAS  Google Scholar 

  29. Lucotte G, La Garde JP, and members of the FOP European Research Group (2007) Mutations of the noggin and of the activin A type I receptor genes in fibrodysplasia ossificans progressiva (FOP). Genet Couns 18:349–352

    PubMed  CAS  Google Scholar 

  30. Xu M-Q, Feldman G, Le Merrer M, Shugart YY, Glaser DL, Urtizberea JA, Fardeau M, Connor JM, Triffitt J, Smith R, Shore EM, Kaplan FS (2000) Linkage exclusion and mutational analysis of the noggin gene in patients with fibrodysplasia ossificans progressiva. Clin Genet 58:291–298

    Article  PubMed  CAS  Google Scholar 

  31. Cohen MM Jr (2002) Bone morphogenetic proteins with some comments on fibrodysplasia ossificans progressiva and noggin. Am J Med Genet 109:87–92

    Article  PubMed  Google Scholar 

  32. Carey JC (2002) Editor’s note. Am J Med Genet 109:160

    Article  Google Scholar 

  33. Xu M, Shore EM, Kaplan FS (2002) Reported noggin mutations are PCR errors. Am J Med Genet 109:161

    Article  PubMed  Google Scholar 

  34. Warman ML (2002) Significant difference of opinion regarding the role of noggin in fibrodysplasia ossificans progressiva. Am J Med Genet 109:162

    Article  PubMed  Google Scholar 

  35. Deirmengian GK, Hebela NM, O’Connell M, Glaser DL, Shore EM, Kaplan FS (2008) Proximal tibial osteochondromas in patients with fibrodysplasia ossificans progressiva (FOP). J Bone Joint Surg Am 90:366–374

    Article  PubMed  Google Scholar 

  36. Kaplan FS, McCluskey W, Hahn G, Tabas J, Muenke M, Zasloff MA (1993) Genetic transmission of fibrodysplasia ossificans progressiva. J Bone Joint Surg Am 75:1214–1220

    PubMed  CAS  Google Scholar 

  37. Hebela N, Shore EM, Kaplan FS (2005) Three pairs of monozygotic twins with fibrodysplasia ossificans progressiva: the role of environment in the progression of heterotopic ossification. Clin Rev Bone Miner Metab 3:205–208

    Article  Google Scholar 

  38. Kaplan FS, Groppe J, Pignolo RJ, Shore EM (2007) Morphogen receptor genes and metamorphogenes: skeleton keys to the metamorphosis. Ann N Y Acad Sci 1116:113–133

    Article  PubMed  CAS  Google Scholar 

  39. Urist MR (1965) Bone formation by autoinduction. Science 150:893–899

    Article  PubMed  CAS  Google Scholar 

  40. Urist MR, Nakagawa M, Nakata N, Nogami H (1978) Experimental, myositis ossificans: cartilage and bone formation in muscle in response to a diffusable bone matrix-derived morphogen. Arch Pathol Lab Med 102:312–316

    PubMed  CAS  Google Scholar 

  41. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA (1988) Novel regulators of bone formation: molecular clones and activities. Science 242:1528–1534

    Article  PubMed  CAS  Google Scholar 

  42. Gannon FH, Glaser D, Caron R, Thompson LD, Shore EM, Kaplan FS (2001) Mast cell involvement in fibrodysplasia ossificans progressiva. Hum Pathol 32:842–848

    Article  PubMed  CAS  Google Scholar 

  43. Kan L, Hu M, Gomes WA, Kessler JA (2004) Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype. Am J Pathol 165:1107–1115

    PubMed  CAS  Google Scholar 

  44. Kan L (2005) The neuron-specific enolase-bone morphogenetic protein 4 transgenic mouse. Clin Rev Bone Miner Metab 3: 235–237

    Article  Google Scholar 

  45. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T (1994) Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127: 1755–1766

    Article  PubMed  CAS  Google Scholar 

  46. Akiyama S, Katagiri T, Namiki M, Yamaji N, Yamamoto N, Miyama K, Shibuya H, Ueno N, Wozney JM, Suda T (1997) Constitutively active BMP type I receptors transduce BMP2 signals without the ligand in C2C12 myoblasts. Exp Cell Res 235:362–369

    Article  PubMed  CAS  Google Scholar 

  47. Massagué J (2000) How cells read TGF-β signals. Nat Rev Mol Cell Biol 1:169–178

    Article  PubMed  Google Scholar 

  48. Hoffman A, Gross G (2001) BMP signaling pathways in cartilage and bone formation. Crit Rev Eukaryot Gene Expr 11:23–45

    Google Scholar 

  49. ten Dijke P, Korchynskyi O, Valdimarsdottir G, Goumans MJ (2003) Controlling cell fate by bone morphogenetic protein receptors. Mol Cell Endocrinol 211:105–113

    Article  PubMed  Google Scholar 

  50. Kloen P, Di Paola M, Borens O, Richmond J, Perino G, Helfet DL, Goumans MJ (2003) BMP signaling components are expressed in human fracture callus. Bone (NY) 33:362–371

    CAS  Google Scholar 

  51. Gazzerro E, Canalis E (2006) Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 7:51–65

    Article  PubMed  CAS  Google Scholar 

  52. Shi Y, Massagué J (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685–700

    Article  PubMed  CAS  Google Scholar 

  53. Massagué J, Seoane J, Wotton D (2005) Smad transcription factors. Genes Dev 19:2783–2810

    Article  PubMed  Google Scholar 

  54. Schmierer B, Hill CS (2007) TGFβ-SMAD signal transduction: molecular specificity and functional flexibility. Mol Cell Biol 8:970–982

    CAS  Google Scholar 

  55. Lander AD (2007) Morpheus unbound: reimagining the morphogen gradient. Cell 128:245–256

    Article  PubMed  CAS  Google Scholar 

  56. Kaplan FS, Tabas JA, Zasloff MA (1990) Fibrodysplasia ossificans progressiva (FOP): a clue from the fly? Calcif Tissue Int 47: 117–125

    Article  PubMed  CAS  Google Scholar 

  57. Shafritz AB, Shore EM, Gannon FH, Zasloff MA, Taub R, Muenke M, Kaplan FS (1996) Over-expression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med 335: 555–561

    Article  PubMed  CAS  Google Scholar 

  58. Gannon FH, Kaplan FS, Olmsted E, Finkel G, Zasloff MA, Shore EM (1997) Bone morphogenetic protein 2/4 in early fibromatous lesions of fibrodysplasia ossificans progressiva. Hum Pathol 28: 339–343

    Article  PubMed  CAS  Google Scholar 

  59. Ahn J, Serrano de la Peña L, Shore EM, Kaplan FS (2003) Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis. J Bone Joint Surg Am 85:667–674

    PubMed  Google Scholar 

  60. Serrano de la Peña L, Billings PC, Fiori JL, Ahn J, Shore EM, Kaplan FS (2005) Fibrodysplasia ossificans progressiva, a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA. J Bone Miner Res 20:1168–1176

    Article  Google Scholar 

  61. Fiori JL, Billings PC, Serrano de la Peña L, Kaplan FS, Shore EM (2006) Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva. J Bone Miner Res 21:902–909

    Article  PubMed  CAS  Google Scholar 

  62. Kaplan FS, Fiori J, Serrano de la Peña L, Ahn J, Billings PC, Shore EM (2006) Dysregulation of the BMP4 signaling pathway in fibrodysplasia ossificans progressiva. Ann N Y Acad Sci 1068: 54–65

    Article  PubMed  CAS  Google Scholar 

  63. Billings PC, Fiori JL, Bentwood JL, O’Connell MP, Jiao X, Nussbaum B, Caron RJ, Shore EM, Kaplan FS (2008) Dysregulated BMP4 signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressiva. J Bone Miner Res 23:305–313

    Article  PubMed  CAS  Google Scholar 

  64. Harradine KA, Akhurst RJ (2006) Mutations of TGF-β signaling molecules in human disease. Ann Med 38:403–414

    Article  PubMed  CAS  Google Scholar 

  65. Zhang D, Schwarz EM, Rosier RN, Zuscik MJ, Puzas JE, O’Keefe RJ (2003) Alk2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development. J Bone Miner Res 18:1593–1604

    Article  PubMed  CAS  Google Scholar 

  66. Fukada T, Kohda M, Kanomata K, Nojima J, Kamizono J, Oda H, Nakayama K, Ohtake A, Miyazono K, Jimi E, Owan I, Okazaki Y, Katagiri T (2007) A constitutively activated BMP receptor, ALK2, induces heterotopic bone formation in patients with fibrodysplasia ossificans progressiva. J Bone Miner Res 22(suppl 1): S10

    Google Scholar 

  67. Shen Q, Xu M, Little SC, Kaplan FS, Mullins MC, Shore EM (2007) Activation of BMP signaling by the FOP ACVR1 R206H mutation. J Bone Miner Res 22(suppl 1):S43

    Google Scholar 

  68. Groppe JC, Shore EM, Kaplan FS (2007) Functional modeling of the ACVR1 (R206H) mutation in FOP. Clin Orthop Relat Res 462:87–92

    Article  PubMed  Google Scholar 

  69. Wang T, Li B-Y, Danielson PD, Shah PC, Rockwell S, Lechleider RJ, Martin J, Manganaro T, Donahoe PK (1996) The immunophilin FKBP12 functions as a common inhibitor of the TGF-β family type I receptors. Cell 86:435–444

    Article  PubMed  CAS  Google Scholar 

  70. Chen Y-G, Liu F, Massagué J (1997) Mechanism of TGF-β receptor inhibition by FKBP12. EMBO J 16:3866–3876

    Article  PubMed  CAS  Google Scholar 

  71. Huse M, Chen YG, Massagué J, Kuriyan J (1999) Crystal structure of the cytoplasmic domain of the type I TGF-β receptor complex with FKBP12. Cell 96:425–436

    Article  PubMed  CAS  Google Scholar 

  72. Huse M, Muir TW, Xu L, Chen YG, Kuriyan J, Massagué J (2001) The TGF-β receptor activation process: an inhibitor-to-substrate binding switch. Mol Cell 8:671–682

    Article  PubMed  CAS  Google Scholar 

  73. Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, Miyazono K (2001) Smurf1 interacts with transforming growth factor-β type 1 receptor through Smad 7 and induces receptor degradation. J Biol Chem 276:12477–12480

    Article  PubMed  CAS  Google Scholar 

  74. Yamaguchi T, Kurisaki A, Yamakawa N, Minakuchi K, Sugino H (2006) FKBP12 functions as an adaptor of the Smad7-Smurf1 complex on activin type I receptor. J Mol Endocrinol 36:569–579

    Article  PubMed  CAS  Google Scholar 

  75. Kaplan FS, Shore EM, Gupta R, Billings PC, Glaser DL, Pignolo RJ, Graf D, Kamoun M (2005) Immunological features of fibrodysplasia ossificans progressiva and the dysregulated BMP4 pathway. Clin Rev Bone Miner Metab 3:189–193

    Article  Google Scholar 

  76. Olmsted-Davis E, Gannon FH, Ozen M, Ittmann MM, Gugala Z, Hipp JA, Moran KM, Fouletier-Dilling CM, Schumara-Martin S, Lindsey RW, Heggeness MH, Brenner MK, Davis AR (2007) Hypoxic adipocytes pattern early heterotopic bone formation. Am J Pathol 170:620–632

    Article  PubMed  CAS  Google Scholar 

  77. Kaplan FS, Le Merrer M, Glaser DL, Pignolo RJ, Goldsby R, Kitterman JA, Groppe J, Shore EM (2008) Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol 22:191–205

    Article  PubMed  CAS  Google Scholar 

  78. Hakim M, Hage W, Lovering RM, Moorman CT III, Curl LA, De Deyne PG (2005) Dexamethasone and recovery of contractile tension after a muscle injury. Clin Orthop Relat Res 439:235–242

    Article  PubMed  Google Scholar 

  79. Järvinen TA, Järvinen TL, Kääriäinen M, Kalimo H, Järvinen M (2005) Muscle injuries: biology and treatment. Am J Sports Med 33:745–764

    Article  PubMed  Google Scholar 

  80. Wynn TA (2007) Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117:524–529

    Article  PubMed  CAS  Google Scholar 

  81. Vanden Bossche LC, Van Maele G, Wojtowicz I, De Cock K, Vertriest S, De Muynck M, Rimbaut S, Vanderstraeten GG (2007) Free radical scavengers are more effective than indomethacin in the prevention of experimentally induced heterotopic ossification. J Orthop Res 25:267–272

    Article  Google Scholar 

  82. Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M, Johnson RS (2001) Hypoxia in cartilage: HIF-1 alpha is essential for chondrocyte growth arrest and survival. Genes Dev 15: 2865–2876

    PubMed  CAS  Google Scholar 

  83. Pfander D, Cramer T, Schipani E, Johnson RS (2003) HIF-1-alpha controls extracellular matrix synthesis by epiphyseal chondrocytes. J Cell Sci 116:1819–1826

    Article  PubMed  CAS  Google Scholar 

  84. Provot S, Ziny KD, Gunes Y, Kathri R, Le Q, Kronenberg HM, Johnson RS, Longaker MT, Giaccia AJ, Schipani E (2007) Hif-1-alpha regulates differentiation of limb bud mesenchyme and joint development. J Cell Biol 177:451–464

    Article  PubMed  CAS  Google Scholar 

  85. Kaplan FS, Glaser DL, Shore EM, Pignolo RJ, Xu M, Zhang Y, Senitzer D, Forman SJ, Emerson SG (2007) Hematopoietic stemcell contribution to ectopic skeletogenesis. J Bone Joint Surg Am 89:347–357

    Article  PubMed  Google Scholar 

  86. Stoick-Cooper CL (2007) Advances in signaling in vertebrate regeneration as a prelude to regenerative medicine. Genes Dev 21:1292–1315

    Article  PubMed  CAS  Google Scholar 

  87. Glaser DL, Kaplan FS (2005) Treatment considerations for the management of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 3:243–250

    Article  Google Scholar 

  88. Shah PB, Zasloff MA, Drummond D, Kaplan FS (1994) Spinal deformity in patients who have fibrodysplasia ossificans progressiva. J Bone Joint Surg Am 76:1442–1450

    PubMed  CAS  Google Scholar 

  89. Kaplan FS, Glaser DL, Pignolo RJ, Shore EM (2007) A new era for fibrodysplasia ossificans progressiva: a druggable target for the second skeleton. Expert Opin Biol Ther 7:705–712

    Article  PubMed  CAS  Google Scholar 

  90. Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, Hoyng SA, Lin HY, Bloch KD, Peterson RT (2008) Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 4:33–41

    Article  PubMed  CAS  Google Scholar 

  91. Mohler ER III, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS (2001) Bone formation and inflammation in cardiac valves. Circulation 20:1522–1528

    Google Scholar 

  92. Pignolo RJ, Foley KL (2005) Nonhereditary heterotopic ossification: implications for injury, arthropathy, and aging. Clin Rev Bone Miner Metab 3:261–266

    Article  Google Scholar 

  93. Wolf JM (2006) The genetic key to a rare disease and its impact on orthopedics. Orthopedics 29:672

    PubMed  Google Scholar 

  94. Potter BK, Burns TC, Lacap AP, Granville RR, Gajkewski D (2006) Heterotopic ossification in the residual limbs of traumatic and combat-related amputees. J Am Acad Orthop Surg 14: S191–S197

    PubMed  Google Scholar 

  95. Kaplan FS (2006) The key to the closet is the key to the kingdom: a common lesson of rare diseases. Orphan Disease Update 24:1–9

    Google Scholar 

  96. Willis R (1989) The Works of William Harvey. University of Pennsylvania Press, Philadelphia, pp 616-617

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Frederick S. Kaplan.

About this article

Cite this article

Kaplan, F.S., Shen, Q., Lounev, V. et al. Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP). J Bone Miner Metab 26, 521–530 (2008). https://doi.org/10.1007/s00774-008-0879-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00774-008-0879-8

Key words

Navigation